HOME >> MEDICINE >> NEWS
Refined stem cell therapy helps paralyzed rats recover

A therapy that combines differentiated stem cells with myelin inhibitors and a motor axon tropic factor helped paralyzed rats restore functional motor units and gain some physical recovery. "This is the first report, to our knowledge, of the anatomical and functional replacement of a motor neuron circuit within the adult, mammalian host," the authors report. The study is in the July issue of Annals of Neurology, a journal published by John Wiley & Sons. The article is also available online via Wiley Interscience (www.interscience.wiley.com/journal/ana).

Scientists' ability to differentiate stem cells toward specific mature cell lineages is assisting in the study of diseases and the development of new treatments. Embryonic stem cells can be induced to create normal pathways for the generation of spinal motor neurons, and this activity can be encouraged by certain pharmacologic agents. The results could help victims of paralysis regain motor function.

Based on this hypothesis, researchers led by Douglas Kerr, M.D., Ph.D. of Johns Hopkins University School of Medicine explored different strategies to restore motor function in paralyzed rats. They used agents to inhibit myelin-mediated axon repulsion and others to provide attractive cues within peripheral nerves. They hoped to stimulate the formation of functional muscular units.

They began by inducing embryonic stem cells from rats to differentiate into motor neurons. They then injected the neurons near the spinal cords of rats that had been paralyzed by a virus. To explore treatment strategies, they divided the rats into 8 groups. Some received neurons that had been treated to potentially increase their survival and their ability to extend axons. Some groups received injections of Rolipram and dibutyrl cAMP to potentially neutralize the inhibitory effects of myelin on axon outgrowth. And some groups received a motor axon tropic factor,
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
21-Jun-2006


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
4. Hormone therapy offers new hope for ovarian cancer patients
5. Borderline personality disorder shows improvements with intensive psychotherapy
6. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
7. Chemotherapy may enhance the effectiveness of brain tumor vaccines
8. Brain-boosting pill alleviates post-chemotherapy fogginess
9. Adding radioimmunotherapy to chemo may help patients with lymphoma
10. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
11. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Refined stem cell therapy helps paralyzed rats recover

(Date:4/28/2015)... 2015 Foot and Ankle Specialists ... D. Palmer ( Annapolis and Clarksville Divisions ) ... at the Maryland Podiatric Medical Association meeting on April ... University in 1992 with a Bachelor of Arts in ... in intercollegiate soccer, track and cross-country. He then attended ...
(Date:4/27/2015)... 2015 Churchview Supportive Living, a Gardant ... Brunch and Fashion Show from 10:30 a.m. to noon ... at 2626 W. 63rd St. in Chicago, serves low-income ... help to maintain their independence. , “Mothers, grandmothers, godmothers ... Mother’s Day Brunch,” said Director of Marketing Elizabeth Clippard. ...
(Date:4/27/2015)... 28, 2015 Healthcare marketing specialists ... called “Website Anatomy 101.” Available for ... necessary design elements for a successful hospital website. ... design, user experience, search results and lead generation ... a well-designed website on patient volume and retention. ...
(Date:4/27/2015)... Tennessee (PRWEB) April 27, 2015 A variety ... help young people trapped in substance abuse. Programming for Jericho ... will serve girls, is launching this summer. , The first ... than $100,000 to serve adolescents. The Youth Town Jim Jackson ... Collierville on Monday, May 4, with tee times at 8 ...
(Date:4/27/2015)... 2015 "Understanding Mental Disorders: Your Guide ... by American Psychiatric Publishing, a division of the American ... at the National Press Club in Washington, D.C.. The ... by APA President Paul Summergrad, MD. Guest speakers will ... foreword to the book; Paul Gionfriddo, President and CEO ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives Maryland Podiatric Medical Association Outstanding Service Award 2Health News:Churchview Supportive Living Community in Chicago to Host Mother's Day Brunch 2Health News:Smith & Jones Publishes 2015 Website Design White Paper 2Health News:Golf, Sermon on the Mount and More to Support Youth Town’s Jericho and Eden Programs 2Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2
(Date:4/27/2015)... , April 27, 2015 Harwood Feffer LLP ... board of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or ... board has breached its fiduciary duties to shareholders. ... press release announcing results from its first Phase 3 ... release disclosed that in the trial, Rhopressa failed to ...
(Date:4/27/2015)... Bronstein, Gewirtz & Grossman, LLC is investigating ... of Celladon Corporation ("Celladon" or the "Company") (NasdaqGM: CLDN ... Bronstein or his investor relations coordinator Eitan ... The investigation concerns whether Celladon and certain of ... 20(a) of the Securities Exchange Act of 1934.  ...
(Date:4/27/2015)... 2015  Eiger BioPharmaceuticals, Incorporated today announced the presentation ... in patients with chronic hepatitis delta viral (HDV) infection. ... at Ankara University Medical School, Turkey ... LOWR HDV - 1 (LOnafarnib With and ... randomized subjects to receive different doses of lonafarnib with ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Celladon Corporation 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3
Cached News: